Hemant Surgical Reports Strong H1 FY27 Results with Multi-Fold Profit Growth
Hemant Surgical Industries Ltd · Financial Result · 14 Nov 2026, 9:42 pm
Hemant Surgical Reports Strong H1 FY27 Results with Multi-Fold Profit Growth Hemant Surgical Industries reported consolidated revenue from operations of ₹27,631.06 lakhs for the half year ended 30th Sep'26, up 327.6% YoY from ₹6,462.01 lakhs in H1 FY26. Consolidated net profit attributable to owners surged 245% YoY to ₹1,883.82 lakhs against ₹545.98 lakhs. Basic EPS rose to ₹13.30 from ₹5.15 YoY. Standalone revenue and PAT stood at ₹27,592.01 lakhs and ₹1,911.75 lakhs, respectively. The company also integrated Lifesenz Cancer Research Labs as a 66.66% subsidiary effective 1st Jun'26.
Original exchange filing (PDF)
More announcements from Hemant Surgical Industries Ltd
- Unaudited Financial Results (standalone and consolidated) of the Company for half year ended September 30, 2026 · 14 Nov 2026
- Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial .... · 14 Nov 2026
- Scrutinizer Report and Voting result of AGM held on September 29, 2026 · 30 Sept 2026
- Proceeding of AGM held on Tuesday, September 29, 2026 · 30 Sept 2026
- The Company has sent letters to those shareholders whose email addresses are not registered. · 05 Sept 2026
- Notice of AGM and Integrated Annual Report for F.Y. 25-26 · 05 Sept 2026
- 37th AGM of the Company is scheduled to be held on September 29, 2026 through VC/OAVM. · 05 Sept 2026
- The Company has considered and decided to hold AGM of the Company on September 29, 2026 through VC/OAVM. · 29 Aug 2026
